This issue of Dialogues in Clinical Neuroscience is devotedto circadian rhythms and related disorders. Many patientswith psychiatric disorders show disturbances in circadianrhythms and frequently sleep disorders. These disorders areconsidered either to be the cause or the symptoms of thecorresponding psychiatric disorder. Whether they be thecause or the effect, it is important to take them into con-sideration for treatment decisions. Specific treatments,such as melatonin, light therapy, advanced and delayedsleep phase, and sleep deprivation, are reported here.Chronobiology (circadian, ultrarapid, and seasonalrhythms) is an essential component of human and animallives. Disturbances in these rhythms result in behaviorabnormalities and mental and somatic symptoms.Exceptionally, in this issue two State of the art articles illus-trate the current knowledge of the complexity of circadianrhythms. In the first, Anna Wirz-Justice (page 315) refers todiurnal variations of mood and sleep disturbances indepression, leaving open the question of its etiological sig-nificance. Antidepressant treatments, medication, sleepdeprivation, and exposure to bright light (corresponding tosunlight) are discussed. The opposite of lightdarknessand the hormone melatonin are examined, as well as futureaspects, which are delineated in an extensive manner.The second State of the art article by Alain Reinberg andIsrael Ashkenazi (page 327) is more conceptualized, relat-ing biological rhythms to environmental factors as adap-tive phenomena to the movement of the earth. In thissophisticated text, they focus on human chronobiologyand the problem of desynchronization, which can occurwithout clinical symptoms (which they call allochronism)or with numerous pathological symptoms (dyschronism).They describe diseases with chronic sleep disturbances, forexample, night shift workers who are intolerant to desyn-chronization.The Basic research article by Paul Pévet (page 343) focus-es on the sleep hormone melatonin. The paper elucidatesthe role of melatonin in animals with special respect to cir-cadian and seasonal rhythms. The administration of exoge-nous melatonin shows the complexity of melatoninsactions. Depending on the dosage, the time of administra-tion, and the sensitivity of melatonin receptors, differenteffects are reported. Melatonin has various effects, whichare mediated through the different melatonin receptors.Pharmacological treatment with melatonin or similar sub-stances has to consider this complexity.Two articles in this issue deal with chronobiological disor-ders and techniques of light therapy. In the Pharmaco-logical aspects article, Barbara L. Parry and Eva L. Mau-rer (page 353) focus on phototherapy and its possiblemechanisms in various psychiatric conditions and subsyn-dromal states, including gender issues like premenstrualdysphoric disorder. It is a comprehensive article coveringmost of the existing relevant literature related to this topic.More clinical aspects are covered in the Poster by UlrichVoderholzer (page 366) on sleep deprivation therapy, whichis one of the most effective therapies for severe depression.Unfortunately, it is only short-lasting, but its effect can beprolonged in combination with pharmacotherapy,advanced sleep phase therapy, and light therapy. Predictorsfor the response to sleep deprivation therapy from brainimaging and endocrine studies are discussed.Sleep disorders are strongly related to disturbances of cir-cadian rhythms and are comprehensively described in theClinical research article by Vivien C. Abad and ChristianGuilleminault (page 371). They describe exactly the differ-ent forms of sleep disorders and present guidelines fortreatment. Additionally, other circadian rhythm disordersare mentioned and options for treatment with chronother-apy and light therapy are given. Restless legs syndrome,periodic limb movement disorders, obstructive sleep apnea,narcolepsy, and parasomnia are comprehensively discussed.The second article to deal with light therapy is a Clinicalresearch article from Nicole Praschak-Rieder andMatthäus Willeit (page 389). It covers the treatment ofmood and also seasonal affective disorder (SAD), whichmay be a subform of major depression, recurrent, orbipolar disorder. The current knowledge of the patho-physiology of SAD and the various treatments with brightlight are presented as a first-line option for SAD. Recom-mendations for the general management of such disor-ders are given, also mentioning a combination of thera-pies with psychotropic drugs.3 1 3I n t h i s i s s u e . . .